Loading…
Wednesday September 16, 2026 11:00am - 11:30am EDT
Using UroGen’s evolution from JELMYTO to ZUSDURI as a real-world lens, the discussion would explore how market intelligence informs executive decision-making as a company and its portfolio mature. It would move from the lessons gained through JELMYTO, to how those insights informed decisions around ZUSDURI and the broader portfolio, and ultimately to how leadership evaluates future internal and external growth opportunities.
 
  • What the first commercial success teaches you about the next opportunity
  • How leaders decide whether to build, buy, partner or pass
  • When intelligence provides the conviction to act or signals it is time to walk away
 



Speakers
avatar for Liz Barrett

Liz Barrett

President and Chief Executive Officer, UroGen
Liz is a highly regarded industry leader with extensive experience leading, building and growing organizations at Fortune 100 pharmaceutical companies before moving to a biotech company. She has been recognized as one of Fortune’s Most Powerful Women and Forbes 50 over 50 among... Read More →
avatar for Timothy Simon

Timothy Simon

SVP, Business Development and Portfolio Strategy, UroGen
Timothy Simon is a seasoned pharmaceutical executive with broad experience spanning Commercial Operations, M&A, Corporate Development, and Product Portfolio Strategy. He brings a strong track record of leadership across both large pharmaceutical companies and emerging biotech firms.Before... Read More →
Wednesday September 16, 2026 11:00am - 11:30am EDT
Junior Ballroom

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link